Characterization of Reference Materials with an Association for Molecular Pathology Pharmacogenetics Working Group Tier 2 Status: CYP2C9, CYP2C19, VKORC1, CYP2C Cluster Variant, and GGCX
Victoria M. Pratt(Indiana University – Purdue University Indianapolis), Lisa V. Kalman(Centers for Disease Control and Prevention), Deborah Vicuna Requesens(Coriell Institute For Medical Research), Francesco Vetrini(Indiana University – Purdue University Indianapolis), Ann M. Moyer(Toyota Motor Corporation (Switzerland)), Amy Turner(Children's Hospital of Wisconsin), Elizabeth B. Medeiros(Indiana University School of Medicine), D. Brian Dawson(B. J. Medical College & Sassoon Hospital), Andrea Gaedigk(Mercy Research), Ulrich Broeckel(Medical College of Wisconsin), Ty C. Lynnes(Indiana University – Purdue University Indianapolis)
Cited by 17
Related Papers
TFEB Links Autophagy to Lysosomal Biogenesis
|Science|2011|3.3k
A lysosome‐to‐nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB
|The EMBO Journal|2012|1.9k
TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop
|Nature Cell Biology|2013|1k
Use of Exome Sequencing for Infants in Intensive Care Units
|Archives of Pediatrics and Adolescent Medicine|2017|435
Reanalysis of Clinical Exome Sequencing Data
|New England Journal of Medicine|2019|303